Jul 31,2018

Voluntis announces the launch of Theraxium Oncology, an innovative digital platform for symptom management

Voluntis, a digital biotech specialized in digital therapeutics, announces the launch its Theraxium Oncology offer, a breakthrough technology that leverages digital therapeutics to empower patients so they can self-manage their symptoms, experienced when receiving cancer treatments, in coordination with care teams.

PRODUCT

#dtx

#mobile app

#platform

View Analyst & Ambassador Comments
Go to original news
Jun 30,2018

How Can Teledermoscopy Services Support Your Practice?

As teledermatology services have gained popularity in recent years, so has the software's benefits. Built on a foundation of streamlining care and increased accessibility, teledermoscopy services such as DermEngine have become a popular example of a service designed to alleviate some of the many pressures found in the dermoscopy industry. Additionally, due to the fact that skin cancer early detection is essential to survival rates (for example, survival rates of 98% versus as low as 16% for cases left undetected until later stages of melanoma) teledermoscopy is able to provide patients with virtually immediate care.

PRODUCT

#connected device

View Analyst & Ambassador Comments
Go to original news
Jun 20,2018

New Tissue-Imaging Technology could Enable Real-Time Diagnostics, Map Cancer Progression

A new microscope system can image living tissue in real time and in molecular detail, without any chemicals or dyes, report researchers at the University of Illinois. The system uses precisely tailored pulses of light to simultaneously image with multiple wavelengths. This enables the researchers to study concurrent processes within cells and tissue, and could give cancer researchers a new tool for tracking tumor progression and physicians new technology for tissue pathology and diagnostics.

CLINICAL STUDY
View Analyst & Ambassador Comments
Go to original news
Jun 01,2018

Astellas Oncology C3 Prize® Returns for Third Year with Focus on Improving -Cancer Care in Underserved Regions of the World-

Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today announced the launch of the third annual Astellas Oncology C3 Prize (Changing Cancer Care), a global challenge aimed at inspiring non-treatment ideas that may improve cancer care for patients and their loved ones. This year’s challenge will focus on solutions for cancer care in low- and middle-income countries, which bear a disproportionate burden of the global cancer epidemic.

View Analyst & Ambassador Comments
Go to original news
May 30,2018

Kaiku Health follow-up algorithm for cancer patients treated with immunotherapy enters a multi-center clinical trial

A novel follow-up algorithm for cancer immunotherapy, developed by digital health company Kaiku Health, is undergoing clinical validation in a multi-center trial conducted at Oulu University Hospital, Turku University Hospital and Docrates Cancer Center in Finland.

PRODUCT

#ai/software

#ml

View Analyst & Ambassador Comments
Go to original news
May 10,2018

Maryam Sadeghi: Startup Grind Female Leader Chatting About Intelligent Dermoscopy Tools

Maryam Sadeghi, CEO of MetaOptima will be speaking at Startup Grind's Women Leaders Event in Vancouver. Along with two other CEOs, Maryam will be chatting about the importance of developing intelligent dermoscopy tools in healthcare, and sharing her personal experience about the challenges and rewards of being a successful female CEO in the digital health supercluster industry here in British Columbia.

#ai/software

#connected device

View Analyst & Ambassador Comments
Go to original news
May 25,2018

MetaOptima Attending SCC & ACDASM

MetaOptima Team is attending the Australasian Skin Cancer Congress from May 25th to 27th in Queensland, Australia. Additionally, last week AUS/NZ Sales Manager, Darren, CTO & Co-Founder, Majid Razmara, and CEO & Co-Founder, Maryam Sadeghi attended the Australasian College of Dermatology's 51st Annual Scientific Meeting from May 19th-22nd to network with key opinion leaders while discussing how intelligent dermatology software can support their practice.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
May 31,2018

Siemens Healthineers and ScreenPoint Medical Sign Agreement to Jointly Develop AI-Based Applications in Breast Imaging

Siemens Healthineers and ScreenPoint Medical have agreed to partner to develop artificial intelligence based applications for breast imaging. This collaborative arrangement also includes the acquisition of a strategic minority stake in ScreenPoint Medical by Siemens Healthineers.

COLLABORATION PARTNERSHIP

#r&d

#ai/software

View Analyst & Ambassador Comments
Go to original news
May 01,2018

Pivotal Study Validates Real-World Mortality Endpoint for Oncology Research

Today, Flatiron Health, a market leader in the curation of regulatory-grade real-world data for cancer research and real-world evidence (RWE) generation, announced the publication of a pivotal study validating the quality of Flatiron’s mortality endpoint and illustrating the potential impact for research conducted with contemporary real-world datasets. The published study details how investigators created a novel real-world mortality endpoint using multiple data sources to supplement Flatiron’s curated electronic health record data, collected from the company’s network of over 2,500 oncology clinicians.

CLINICAL STUDY

#rwd

#rwe

View Analyst & Ambassador Comments
Go to original news
May 01,2018

Bristol-Myers Squibb and Flatiron Health Expand Collaboration with a Three-Year Agreement

Bristol-Myers Squibb and Flatiron Health expanded their relationship today by announcing a three-year collaboration agreement. Bristol-Myers Squibb will use Flatiron’s real-world data to accelerate its research and development efforts, as well as improve its ability to generate additional evidence on the use of its cancer medicines outside of clinical trials. With the expanded collaboration, the two companies intend to form a joint Scientific Advisory Board to advance the use of RWE for regulatory decision making.

COLLABORATION PARTNERSHIP

#product & service

#rwd

#rwe

View Analyst & Ambassador Comments
Go to original news
Subscribe to ONCOLOGY